Form 4: Clorox Director Boosts Stake with 4,000 Share Purchase

Clorox Director Pierre R. Breber acquired 4,000 shares of common stock at a weighted average price of $104.1291 per share through a trust.

Summary

• Pierre R. Breber, a Director of The Clorox Company (CLX), acquired 4,000 shares of the company's common stock.
• The transaction took place on November 21, 2025.
• The shares were purchased at a weighted average price of $104.1291 per share, with individual trade prices ranging from $104.00 to $104.24.
• This acquisition was made indirectly by a trust.
• Following this transaction, the trust beneficially owns a total of 13,000 shares of Clorox common stock.
• The transaction was executed pursuant to a Rule 10b5-1(c) trading plan.

Sentiment

Score: 7

Explanation: A director's purchase of company stock, particularly under a Rule 10b5-1 plan, typically signals confidence in the company's valuation and future prospects, contributing to a moderately positive sentiment.

Positives

• A company director purchasing shares can signal confidence in the company's current valuation and future prospects.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned acquisition and adherence to insider trading policies.

Future Outlook

While the filing itself does not provide explicit forward-looking statements, a director's purchase of company stock is generally interpreted as a positive signal regarding management's belief in the company's future performance and valuation.

Industry Context

Insider buying in the consumer staples sector, particularly for a well-established brand like Clorox, can indicate management's belief in the stability, resilience, or growth potential of the company within its industry, potentially signaling confidence despite broader economic conditions.

Comparison to Industry Standards

• Insider buying is a common practice across all industries, often viewed as a positive indicator of management confidence.
• The execution of the transaction under a Rule 10b5-1 plan aligns with best practices for corporate governance, demonstrating a pre-planned approach to trading that mitigates concerns about trading on non-public information, a standard observed across publicly traded companies.

Corporate Governance

Related Party Transactions

• Director Pierre R. Breber, a related party, acquired 4,000 shares of Clorox common stock indirectly through a trust.

Stakeholder Impact

• Shareholders: May view the director's purchase as a positive signal, potentially boosting investor confidence in the company's future.

Key Dates

Recommendation

The purchase of shares by a director signals confidence in the company's future. However, a single insider transaction, even a positive one, is typically not sufficient on its own to warrant a 'strong buy' or 'strong sell' recommendation without a broader analysis of the company's financial performance, market conditions, and strategic outlook. It serves as a positive data point for existing shareholders and those considering a 'hold' position.

Keywords

Clorox, CLX, Insider Trading, Form 4, Share Purchase, Director, Equity Acquisition, 10b5-1 Plan